Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2403001C Modulating production of pneumococcal capsular polysaccharide
07/03/2012CA2330618C Viral chimeras comprised of caev and hiv-1 genetic elements
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2196555C Vr-2332 viral nucleotide sequence and methods of use
06/2012
06/28/2012WO2012088178A1 Inhibitors of cytochrome p450 (cyp3a4)
06/28/2012WO2012088156A1 Inhibitors of cytochrome p450
06/28/2012WO2012088155A1 Cyclic nucleotide analogs
06/28/2012WO2012088153A1 Inhibitors of cytochrome p450
06/28/2012WO2012087976A2 Novel inhibitors of hepatitis c virus replication
06/28/2012WO2012087833A1 Hepatitis c inhibitors and uses thereof
06/28/2012WO2012087596A1 Combinations for treating hcv
06/28/2012WO2012087181A1 Pharmaceutical composition for treating viral diseases
06/28/2012WO2012087037A2 Novel bacteriophage and antibacterial composition comprising the same
06/28/2012WO2012087004A2 Use of upr signaling pathway genes ire1 and hxl1 for treatment of fungal infection and meningitis
06/28/2012WO2012086889A1 Novel hispidin-based compound having an enoyl-reductase-inhibiting and an antimicrobial activity
06/28/2012WO2012086241A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
06/28/2012WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012WO2012085654A1 Novel anti-tuberculosis agents
06/28/2012WO2012085559A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
06/28/2012WO2012085553A1 Sanglifehrin derivatives and methods for their production
06/28/2012WO2012085304A1 Phosphomycin pharmaceutical composition
06/28/2012WO2012085177A1 Nemaucin, an antibiotic produced by entomopathogenic xenorhabdus cabanillasii
06/28/2012WO2012085171A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012WO2012085003A1 2-hydroxyisoquinoline-1,3(2h,4h)-diones and related compounds useful as hiv replication inhibitors
06/28/2012WO2012084993A2 Biologically active oligonucleotides capable of modulating the immune system i
06/28/2012WO2012084991A1 Biologically active oligonucleotides capable of modulating the immune system ii
06/28/2012WO2012084971A1 Indole derivatives as agents against gram-negative and gram-positive bacteria
06/28/2012WO2012084804A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
06/28/2012WO2012084446A1 Compound having antibacterial activity
06/28/2012WO2012083837A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
06/28/2012WO2012083475A1 Neutralizing polyclonal antibody against hantavirusandes, production method and pharmaceutical compositions
06/28/2012WO2012083445A1 Virus like particle production in plants
06/28/2012WO2012061767A3 Defensin-like molecules as novel antimicrobial agents
06/28/2012WO2012061075A3 Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells
06/28/2012WO2012057525A3 Liquid formulations of long acting interferon alpha conjugate
06/28/2012WO2012051204A3 Antimicrobial formulations that aid in wound healing
06/28/2012WO2012041981A3 Use of growth hormone to enhance the immune response in immunosuppressed patients
06/28/2012WO2012036437A3 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
06/28/2012WO2011153351A3 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
06/28/2012WO2010015703A3 6 - o - substituted 15 -membered 8a- and 9a - lactams
06/28/2012US20120165795 Therapeutic agent reservoir delivery system
06/28/2012US20120165404 Treatment of neurodegeneration and neuroinflammation
06/28/2012US20120165397 Chemical modification of short small hairpin rnas for inhibition of gene expression
06/28/2012US20120165393 Peptide-Based In Vivo siRNA Delivery System
06/28/2012US20120165387 General composition framework for ligand-controlled RNA regulatory systems
06/28/2012US20120165378 Thiophene-carboxamides useful as inhibitors of protein kinases
06/28/2012US20120165369 3-SUBSTITUTED QUINOLINIUM AND 7H-INDOLO[2,3-c]QUINOLINIUM SALTS AS NEW ANTIINFECTIVES
06/28/2012US20120165357 Compositions Containing Berberine or Analogs Thereof for Treating Rosacea or Red Face Related Skin Disorders
06/28/2012US20120165344 Compounds for the Treatment of Hepatitis C
06/28/2012US20120165342 Methods of Reducing Risk of Infection from Pathogens
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165335 Cdk inhibitors
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/28/2012US20120165306 Pyrazinylpyridines useful for the treatment of proliferative diseases
06/28/2012US20120165302 Antifungal formulations
06/28/2012US20120165295 Compounds, Compositions and Methods for Treating Ocular Conditions
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165289 Treatment
06/28/2012US20120165288 Azapeptide derivatives
06/28/2012US20120165286 Cyclic nucleotide analogs
06/28/2012US20120165283 Novel aminoglycoside antibiotics
06/28/2012US20120165282 Antibacterial aminoglycoside analogs
06/28/2012US20120165279 Pharmaceutical composition and method for preventing or treating hepatitis c
06/28/2012US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
06/28/2012US20120165250 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors
06/28/2012US20120165249 Stabilized Therapeutic Small Helical Antiviral Peptides
06/28/2012US20120165248 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
06/28/2012US20120165246 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
06/28/2012US20120165244 Methods for binding lewis y antigen
06/28/2012US20120164253 Anti-influenza viral composition containing bark or stem extract of alnus japonica
06/28/2012US20120164248 Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
06/28/2012US20120164247 Medicinal and herbal composition and uses thereof
06/28/2012US20120164241 Boehmeria extract and its use in treating liver diseases
06/28/2012US20120164240 Enriched a. blitoides compositions and uses thereof
06/28/2012US20120164233 Pulsatile release pharmaceutical formulation of dexlansoprazole
06/28/2012US20120164181 Non-Specific Immunostimulating Agents
06/28/2012US20120164177 Rhinovirus vaccines
06/28/2012US20120164176 Rsv f protein compositions amd methods for making same
06/28/2012US20120164175 Novel influenza virus
06/28/2012US20120164174 Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
06/28/2012US20120164173 Papilloma Pseudovirus and Preparation
06/28/2012US20120164171 Antiviral Activity of Bovine Type III Interferon Against Foot-and-Mouth Disease Virus
06/28/2012US20120164170 Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof
06/28/2012US20120164169 Bovine herpesvirus vaccine
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164156 Recombinant F1-V Plague Vaccine
06/28/2012US20120164155 Chimeric molecules
06/28/2012US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164135 Method for preparing comprehensive anti-surface antibody using microorganism immobilized as antigen with protein crosslinking and immobilization reagent
06/28/2012US20120164126 Proteins for use in human and animal staphyococcus infections
06/28/2012US20120164124 Phage-associated lytic enzymes for treatment of bacillus anthracis and related conditions
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 1798